Revision as of 17:55, 9 January 2012 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Saving copy of the {{chembox}} taken from revid 464461804 of page Staphyloxanthin for the Chem/Drugbox validation project (updated: 'CASNo'). |
Latest revision as of 07:20, 3 July 2023 edit Citation bot (talk | contribs)Bots5,391,856 edits Add: bibcode. | Use this bot. Report bugs. | Suggested by Spinixster | Category:Glucosides | #UCB_Category 7/60 |
Line 1: |
Line 1: |
|
{{ambox | text = This page contains a copy of the infobox ({{tl|chembox}}) taken from revid of page ] with values updated to verified values.}} |
|
|
{{chembox |
|
{{chembox |
|
|
| Verifiedfields = changed |
⚫ |
| verifiedrevid = 449645463 |
|
|
|
| Watchedfields = changed |
|
⚫ |
| verifiedrevid = 470470573 |
|
| Name = Staphyloxanthin |
|
| Name = Staphyloxanthin |
|
| ImageFile = Staphyloxanthin.svg |
|
| ImageFile = Staphyloxanthin.svg |
|
| ImageSize = 350px |
|
| ImageSize = 250px |
|
| ImageName = Chemical structure of staphyloxanthin |
|
| ImageName = Chemical structure of staphyloxanthin |
|
| ImageAlt = Chemical structure of staphyloxanthin |
|
| ImageAlt = Chemical structure of staphyloxanthin |
|
| IUPACName = <nowiki> [(2S,3R,4S,5S,6R)-3,4, |
|
| IUPACName = [(2''S'',3''R'',4''S'',5''S'',6''R'')-3,4, |
|
5-trihydroxy-6-oxymethyl]oxan-2-yl](2E,4E,6E,8E,10E,12E,14E,16E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,22-decaenoate</nowiki> |
|
5-Trihydroxy-6-<nowiki>oxymethyl]oxan-2-yl] (2''E'',4''E'',6''E'',8''E'',10''E'',12''E'',14''E'',16''E'',18''E'')-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,22-decaenoate |
|
| OtherNames = <!-- <br> --> |
|
| OtherNames = |
|
|Section1= {{Chembox Identifiers |
|
|Section1={{Chembox Identifiers |
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID = 4947803 |
|
| ChemSpiderID = 65323059 |
|
|
| ChEBI_Ref = {{ebicite|changed|EBI}} |
|
|
| ChEBI = 71690 |
|
| InChI1 = 1/C51H78O8/c1-10-39(4)25-16-14-12-11-13-15-17-33-44(36-52)51(9,35-23-32-43(8)49(57)59-50-48(56)47(55)46(54)45(37-53)58-50)34-19-18-26-40(5)28-21-30-42(7)31-22-29-41(6)27-20-24-38(2)3/h17-19,21-24,26,28-33,35-36,39,44-48,50,53-56H,10-16,20,25,27,34,37H2,1-9H3/b19-18+,28-21+,31-22+,33-17-,35-23+,40-26+,41-29+,42-30+,43-32+/t39?,44?,45-,46-,47+,48-,50-,51?/m1/s1 |
|
| InChI1 = 1/C51H78O8/c1-10-39(4)25-16-14-12-11-13-15-17-33-44(36-52)51(9,35-23-32-43(8)49(57)59-50-48(56)47(55)46(54)45(37-53)58-50)34-19-18-26-40(5)28-21-30-42(7)31-22-29-41(6)27-20-24-38(2)3/h17-19,21-24,26,28-33,35-36,39,44-48,50,53-56H,10-16,20,25,27,34,37H2,1-9H3/b19-18+,28-21+,31-22+,33-17-,35-23+,40-26+,41-29+,42-30+,43-32+/t39?,44?,45-,46-,47+,48-,50-,51?/m1/s1 |
|
| InChIKey1 = ZGBLADNGFNFPBV-OQMOJWPEBF |
|
| InChIKey1 = ZGBLADNGFNFPBV-OQMOJWPEBF |
Line 19: |
Line 22: |
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChIKey = ZGBLADNGFNFPBV-OQMOJWPESA-N |
|
| StdInChIKey = ZGBLADNGFNFPBV-OQMOJWPESA-N |
|
| CASNo = <!-- blanked - oldvalue: 71869-01-7 --> |
|
| CASNo = 71869-01-7 |
|
| CASNo_Ref = {{cascite|correct|??}}= |
|
| CASNo_Ref = {{cascite|changed|??}} |
|
| CASOther = |
|
| CASNoOther = |
|
| PubChem = 24892781 |
|
| PubChem = 56928085 |
|
| SMILES = O=C(O1O((O)(O)1O)CO)\C(=C\C=C\C(C)(C\C=C\C=C(\C=C\C=C(\C=C\C=C(/C)CC\C=C(/C)C)C)C)C(\C=C/CCCCCCCC(C)CC)C=O)C |
|
| SMILES = O=C(O1O((O)(O)1O)CO)\C(=C\C=C\C(C)(C\C=C\C=C(\C=C\C=C(\C=C\C=C(/C)CC\C=C(/C)C)C)C)C(\C=C/CCCCCCCC(C)CC)C=O)C |
|
| InChI = |
|
| InChI = |
|
| MeSHName = |
|
| MeSHName = |
|
}} |
|
}} |
|
|Section2= {{Chembox Properties |
|
|Section2={{Chembox Properties |
|
|
| C=51 |
|
| Formula = C<sub>51</sub>H<sub>78</sub>O<sub>8</sub> |
|
|
|
| H=78 |
|
| MolarMass = 819.16 g/mol |
|
|
|
| O=8 |
|
| ExactMass = 818.569669 u |
|
|
| Appearance = |
|
| Appearance = |
|
| Density = |
|
| Density = |
|
| MeltingPt = <!-- °C --> |
|
| MeltingPt = |
|
| BoilingPt = <!-- °C --> |
|
| BoilingPt = |
|
| Solubility = |
|
| Solubility = |
|
}} |
|
}} |
|
}} |
|
}} |
|
|
|
|
|
'''Staphyloxanthin''' is a ] ] that is produced by some strains of '']'', and is responsible for the characteristic golden color that gives ''S. aureus'' its species name. Staphyloxanthin also acts as a virulence factor. It has an ] action that helps the microbe evade death by ] produced by the host immune system.<ref name="staphylotoxin">{{cite journal |vauthors=Clauditz A, Resch A, Wieland KP, Peschel A, Götz F |title=Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress |journal=Infection and Immunity |volume=74 |issue=8 |pages=4950–3 |date=August 2006 |pmid=16861688 |pmc=1539600 |doi=10.1128/IAI.00204-06 }}</ref> |
|
|
] staphyloxanthin gave the bacteria '']'' a yellow color.]] |
|
|
When comparing a normal strain of ''S. aureus'' with a strain modified to lack staphyloxanthin, the wildtype pigmented strain was more likely to survive incubation with an oxidizing chemical such as ] than the mutant strain was. Colonies of the two strains were also exposed to human ]. The mutant colonies quickly succumbed while many of the pigmented colonies survived. Wounds on mice were inoculated with the two strains. The pigmented strains created lingering ]es. Wounds with the unpigmented strains healed quickly. These tests suggest that the staphyloxanthin may be key to the ability of ''S. aureus'' to survive immune system attacks. |
|
|
|
|
|
Drugs designed to inhibit the bacterium's production of the staphyloxanthin may weaken it and renew its susceptibility to antibiotics.<ref name="JExpMed2005-Liu">{{cite journal |vauthors=Liu GY, Essex A, Buchanan JT, Datta V, Hoffman HM, Bastian JF, Fierer J, Nizet V | title=Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity | journal=J Exp Med | year=2005 | pages=209–15 | volume=202 | issue=2 | pmid=16009720 | doi=10.1084/jem.20050846 | pmc=2213009}}</ref> In fact, because of similarities in the pathways for biosynthesis of staphyloxanthin and human ], a drug developed in the context of cholesterol-lowering therapy was shown to block ''S. aureus'' pigmentation and disease progression in a ].<ref name="Science2008-Liu">{{cite journal |vauthors=Liu CI, Liu GY, Song Y, Yin F, Hensler ME, Jeng WY, Nizet V, Wang AH, Oldfield E | title=A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence | journal=Science | year=2008 | pages=391–94 | volume=319| pmid=18276850 | doi=10.1126/science.1153018 | issue=5868 | pmc=2747771| bibcode=2008Sci...319.1391L }}</ref> |
|
|
|
|
|
==References== |
|
|
{{reflist}} |
|
|
|
|
|
==External links== |
|
|
* |
|
|
|
|
|
] |
|
|
] |
|
|
] |